John F. Oram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John F. Oram has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Ashley M. Vaughan
6 shared publicationsChongren Tang
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington 98195, USA
4 shared publicationsEdwin L. Bierman
From the Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle
2 shared publicationsGertrud Wolfbauer
‡Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Box 356426, University of Washington, Seattle, Washington 98195 and the §Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45237-0507
2 shared publicationsJay W. Heinecke
2 shared publicationsMark A. Deeg
From the Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle
2 shared publications
Latest Publications
- Open Access
- 1 November 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (47) , 32336-32343
The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor
- 1 November 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (47) , 32336-32343
Open AccessThe Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor
- Open Access
- 1 February 2009
- Published by Elsevier in Journal of Lipid Research
- Vol. 50 (2) , 285-292
ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation
- 1 February 2009
- Published by Elsevier in Journal of Lipid Research
- Vol. 50 (2) , 285-292
Open AccessABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation
- Open Access
- 1 June 2008
- Published by Elsevier in Journal of Lipid Research
- Vol. 49 (6) , 1150-1151
The ins and outs of ABCA
- 1 June 2008
- Published by Elsevier in Journal of Lipid Research
- Vol. 49 (6) , 1150-1151
Open AccessThe ins and outs of ABCA
- Open Access
- 1 April 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (17) , 11541-11549
An Amphipathic Helical Region of the N-terminal Barrel of Phospholipid Transfer Protein Is Critical for ABCA1-dependent Cholesterol Efflux
- 1 April 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (17) , 11541-11549
Open AccessAn Amphipathic Helical Region of the N-terminal Barrel of Phospholipid Transfer Protein Is Critical for ABCA1-dependent Cholesterol Efflux
- 1 December 2007
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 9 (6) , 425-427
When good cholesterol turns bad: The evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein
- 1 December 2007
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 9 (6) , 425-427
When good cholesterol turns bad: The evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein
- Open Access
- 1 May 2007
- Published by Elsevier in Journal of Lipid Research
- Vol. 48 (5) , 1062-1068
Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C δ pathway
- 1 May 2007
- Published by Elsevier in Journal of Lipid Research
- Vol. 48 (5) , 1062-1068
Open AccessUnsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C δ pathway
- 1 April 2007
- Published by Taylor & Francis in Future Lipidology
- Vol. 2 (2) , 185-196
Role of amphipathic α-helical structural elements in removing cellular cholesterol and protecting against cardiovascular disease
- 1 April 2007
- Published by Taylor & Francis in Future Lipidology
- Vol. 2 (2) , 185-196
Role of amphipathic α-helical structural elements in removing cellular cholesterol and protecting against cardiovascular disease
- 10 November 2006
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 99 (10) , 1031-1043
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
A hallmark of atherosclerotic cardiovascular disease (CVD) is the accumulation of cholesterol in arterial macrophages. Factors that modulate circulating and tissue cholesterol levels have major impacts on initiation, progression, and regression of CVD. Four members of the ATP-binding cassette (ABC) transporter family play important roles in this modulation. ABCA1 and ABCG1 export excess cellular cholesterol into the HDL pathway and reduce cholesterol accumulation in macrophages. ABCG5 and ABCG8 form heterodimers that limit absorption of dietary sterols in the intestine and promote cholesterol elimination from the body through hepatobiliary secretion. All 4 transporters are induced by the same sterol-sensing nuclear receptor system. ABCA1 expression and activity are also highly regulated posttranscriptionally by diverse processes. ABCA1 mutations can cause a severe HDL-deficiency syndrome characterized by cholesterol deposition in tissue macrophages and prevalent atherosclerosis. ABCG5 or ABCG8 mutations can cause sitosterolemia, in which patients accumulate cholesterol and plant sterols in the circulation and develop premature CVD. Disrupting Abca1 or Abcg1 in mice promotes accumulation of excess cholesterol in macrophages, and manipulating mouse macrophage ABCA1 expression affects atherogenesis. Overexpressing ABCG5 and ABCG8 in mice attenuates diet-induced atherosclerosis in association with reduced circulating and liver cholesterol. Metabolites elevated in individuals with the metabolic syndrome and diabetes destabilize ABCA1 protein and inhibit transcription of all 4 transporters. Thus, impaired ABC cholesterol transporters might contribute to the enhanced atherogenesis associated with common inflammatory and metabolic disorders. Their beneficial effects on cholesterol homeostasis have made these transporters important new therapeutic targets for preventing and reversing CVD.
- 10 November 2006
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 99 (10) , 1031-1043
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
A hallmark of atherosclerotic cardiovascular disease (CVD) is the accumulation of cholesterol in arterial macrophages. Factors that modulate circulating and tissue cholesterol levels have major impacts on initiation, progression, and regression of CVD. Four members of the ATP-binding cassette (ABC) transporter family play important roles in this modulation. ABCA1 and ABCG1 export excess cellular cholesterol into the HDL pathway and reduce cholesterol accumulation in macrophages. ABCG5 and ABCG8 form heterodimers that limit absorption of dietary sterols in the intestine and promote cholesterol elimination from the body through hepatobiliary secretion. All 4 transporters are induced by the same sterol-sensing nuclear receptor system. ABCA1 expression and activity are also highly regulated posttranscriptionally by diverse processes. ABCA1 mutations can cause a severe HDL-deficiency syndrome characterized by cholesterol deposition in tissue macrophages and prevalent atherosclerosis. ABCG5 or ABCG8 mutations can cause sitosterolemia, in which patients accumulate cholesterol and plant sterols in the circulation and develop premature CVD. Disrupting Abca1 or Abcg1 in mice promotes accumulation of excess cholesterol in macrophages, and manipulating mouse macrophage ABCA1 expression affects atherogenesis. Overexpressing ABCG5 and ABCG8 in mice attenuates diet-induced atherosclerosis in association with reduced circulating and liver cholesterol. Metabolites elevated in individuals with the metabolic syndrome and diabetes destabilize ABCA1 protein and inhibit transcription of all 4 transporters. Thus, impaired ABC cholesterol transporters might contribute to the enhanced atherogenesis associated with common inflammatory and metabolic disorders. Their beneficial effects on cholesterol homeostasis have made these transporters important new therapeutic targets for preventing and reversing CVD.
- 1 October 2005
- Published by American Physiological Society in Physiological Reviews
- Vol. 85 (4) , 1343-1372
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
Blood high-density lipoprotein (HDL) levels are inversely related to risk for cardiovascular disease, implying that factors associated with HDL metabolism are atheroprotective. One of these factors is ATP-binding cassette transporter A1 (ABCA1), a cell membrane protein that mediates the transport of cholesterol, phospholipids, and other metabolites from cells to lipid-depleted HDL apolipoproteins. ABCA1 transcription is highly induced by sterols, a major substrate for cellular export, and its expression and activity are regulated posttranscriptionally by diverse processes. Liver ABCA1 initiates formation of HDL particles, and macrophage ABCA1 protects arteries from developing atherosclerotic lesions. ABCA1 mutations can cause a severe HDL deficiency syndrome characterized by cholesterol deposition in tissue macrophages and prevalent atherosclerosis. Genetic manipulations of ABCA1 expression in mice also affect plasma HDL levels and atherogenesis. Metabolites elevated in individuals with the metabolic syndrome and diabetes destabilize ABCA1 protein and decrease cholesterol export from macrophages. Moreover, oxidative modifications of HDL found in patients with cardiovascular disease reduce the ability of apolipoproteins to remove cellular cholesterol by the ABCA1 pathway. These observations raise the possibility that an impaired ABCA1 pathway contributes to the enhanced atherogenesis associated with common inflammatory and metabolic disorders. The ABCA1 pathway has therefore become an important new therapeutic target for treating cardiovascular disease.
- 1 October 2005
- Published by American Physiological Society in Physiological Reviews
- Vol. 85 (4) , 1343-1372
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
Blood high-density lipoprotein (HDL) levels are inversely related to risk for cardiovascular disease, implying that factors associated with HDL metabolism are atheroprotective. One of these factors is ATP-binding cassette transporter A1 (ABCA1), a cell membrane protein that mediates the transport of cholesterol, phospholipids, and other metabolites from cells to lipid-depleted HDL apolipoproteins. ABCA1 transcription is highly induced by sterols, a major substrate for cellular export, and its expression and activity are regulated posttranscriptionally by diverse processes. Liver ABCA1 initiates formation of HDL particles, and macrophage ABCA1 protects arteries from developing atherosclerotic lesions. ABCA1 mutations can cause a severe HDL deficiency syndrome characterized by cholesterol deposition in tissue macrophages and prevalent atherosclerosis. Genetic manipulations of ABCA1 expression in mice also affect plasma HDL levels and atherogenesis. Metabolites elevated in individuals with the metabolic syndrome and diabetes destabilize ABCA1 protein and decrease cholesterol export from macrophages. Moreover, oxidative modifications of HDL found in patients with cardiovascular disease reduce the ability of apolipoproteins to remove cellular cholesterol by the ABCA1 pathway. These observations raise the possibility that an impaired ABCA1 pathway contributes to the enhanced atherogenesis associated with common inflammatory and metabolic disorders. The ABCA1 pathway has therefore become an important new therapeutic target for treating cardiovascular disease.
- Open Access
- 1 December 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (52) , 52379-52385
Phospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells
- 1 December 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (52) , 52379-52385
Open AccessPhospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells